The domestic market has brought some good news to the US tech giant Apple (AAPL) as its market share increased to 42% in the last quarter of 2013. This is quite obvious as more and more people are shifting to smartphones, and what better than flaunting an iPhone. The growing US smartphone market has been pretty beneficial for the Cupertino company�� rival Samsung as well. The South Korean multinational mobile maker saw its market share increase to 26% in the fourth quarter of 2013.
US buyers prefer to hold an iPhone or a Galaxy over other smartphones, and this is precisely why the two giants dominated the smartphone market with a combined market share of over 60% in the final quarter.
What about other smartphone makers?
Among other smartphone makers LG (LPL) is the only one that witnessed a rise in market share, but it still controls less the 10% of the market. Although the company saw a marginal increase in its market share, it should thank its stars considering other major players��disappointing performance. One of the prime reasons why LG managed a positive market share trend is that it made Google�� (GOOG) Nexus 4 and 5. These handsets did decent enough to pull up LG�� presence in the smartphone arena, although it is way behind Apple�� and Samsung��.
Top Tech Stocks To Watch For 2015: MELA Sciences Inc(MELA)
MELA Sciences, Inc., a medical device company, focuses on the design and development of a non-invasive, point-of-care instrument to assist in the detection of early melanoma. The company?s principal product, MelaFind, features a hand-held imaging device that emits multiple wavelengths of light to capture images of suspicious pigmented skin lesions and extract data. This product uses automatic image analysis and statistical pattern recognition to help identify lesions to be considered for biopsy to rule out melanoma. It consists of hand-held imaging device, which employs high precision optics and multi-spectral illumination; database of pigmented skin lesions; and lesion classifiers, which are mathematical algorithms that extract lesion feature information and classify lesions. MELA Sciences submitted the MelaFind pre-market approval application with the U.S. Food and Drug Administration (FDA) in June 2009 and is under review at the FDA. The company was formerly known as E lectro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.
Advisors' Opinion:- [By Lisa Levin]
MELA Sciences (NASDAQ: MELA) shares reached a new 52-week low of $0.303 after the company approved a one-for-ten reverse stock split of the common stock.
Top 5 Heal Care Companies To Buy For 2014: Concord Medical Services Holdings Limited (CCM)
Concord Medical Services Holdings Limited, together with its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People�s Republic of China. The company�s services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, proton beam therapy, diagnostic imaging, and other treatment and diagnostic modalities. It offers clinical support services; develops treatment protocols for doctors; and organizes joint diagnosis between doctors in its network and clinical research. The company also operates a specialty cancer hospital, as well as leases medical and diagnostic equipment. As of March 31, 2011, it operated a network of 121 centers with 68 hospital partners that cover 46 cities and 24 provinces, and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People�s Republic of China.
Advisors' Opinion:- [By John Udovich]
China is set to ease the one child policy, something that could benefit Chinese stocks in general but be especially beneficial to insurance stocks like China Life Insurance Company Ltd (NYSE: LFC) and CNinsure Inc (NASDAQ: CISG) plus health care stocks like Mindray Medical International Ltd�(NYSE: MR) and Concord Medical Services Hldg Ltd (NYSE: CCM). First, let�� be clear that China is NOT abolishing the one child policy as the changes will merely�allow married couples to have two children if one spouse is an only child plus it will be up to China�� 34 province-level administrations to revise�their laws and put the new policy into effect. Moreover, China�� family-planning bureaucracy employs more than 500,000 full-time workers and six million part-time workers all the way down to the village level to�collect billions of dollars in fines and these bureaucrats have fought for years against policy changes���meaning they could throw up roadblocks if not placated. With that said, the insurance and health care sectors are two sectors with publicly Chinese stocks that look set to�take advantage of the coming changes.
Top 5 Heal Care Companies To Buy For 2014: iShares 10-20 Year Treasury Bond ETF (TLH)
iShares Lehman 10-20 Year Treasury Bond Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the long-term sector of the United States Treasury market as defined by the Lehman Brothers 10-20 Year U.S. Treasury Index (the Index). The Index includes all publicly issued, the United States Treasury securities that have a remaining maturity of greater than or equal to 10 years and less than 20 years, and have $250 million or more of outstanding face value. In addition, the securities must be denominated in United States dollars, and must be fixed-rate and non-convertible securities. Excluded from the Index are certain special issues, such as flower bonds, targeted investor notes, and state and local government series bonds, and coupon issues that have been stripped from assets that are already included in the Index. The Fund generally will invest at least 95% of its assets in the United States Government bonds.
The Index is a market capitalization-weighted index. The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. The Fund�� investment advisor is Barclays Global Fund Advisor.
Advisors' Opinion:- [By Mary Anne & Pamela Aden]
The ones we like best and recommend buying are the iShares 20+ year Treasury Bond (TLT), the iShares 10-20 year Treasury Bond (TLH), Proshares Ultra 20+ year Treasury (UBT) and Pimco Intermediate Muni Bond strategy ETF (MUNI).
- [By Donald van Deventer]
Long-duration Treasury Exchange-Traded Funds: (TLH), , (IEF), (DTYL), (DLBL), (ILTB), (TENZ), (ITE), (TLO), (EDV), (VGIT), (VGLT), (TMF), (TYD), (LBND), (UBT), (UST), (TMV), (TYO), (DSTJ), (DSXJ), (SBND), (PST), (DTYS), (DLBS), (TBF), (TTT), (TYNS), (TYBS), (TBX).
Top 5 Heal Care Companies To Buy For 2014: National Health Investors Inc. (NHI)
National Health Investors, Inc., a real estate investment trust (REIT), invests in health care properties, primarily in the long-term care industry in the United States. As of December 31, 2008, it had investments in real estate assets and mortgage notes receivable investments in 123 health care facilities consisting of 83 long-term care facilities, 1 acute care hospital, 4 medical office buildings, 14 assisted living facilities, 4 retirement centers, and 17 residential projects for the developmentally disabled in 17 states. The company has elected to be treated as a REIT for federal income tax purposes and would not be subject to federal income tax, if it distributes at least 90% of its REIT taxable income to its shareholders. National Health Investors, Inc. was founded in 1991 and is based in Murfreesboro, Tennessee.
Advisors' Opinion:- [By Jonas Elmerraji]
After performing pretty poorly in the last year, $2 billion healthcare property owner National Health Investors (NHI) has gone from laggard to leader in 2014. Since the start of the year, NHI has moved more than 11% higher, stomping the S&P 500's performance by comparison. And now, NHI looks well positioned for another leg up...
NHI is forming a "rounding bottom" pattern, a basic classic setup that looks exactly like it sounds: it's identified by a curved support level below shares and a horizontal resistance level to the top side. That rounded support line indicates a gradual shift in control from sellers to buyers -- and resistance at $63 is the price level to watch from here.
Why all the significance at $63? It all comes down to buyers and sellers. Price patterns are a good quick way to identify what's going on in the price action, but they're not the reason a stock is tradable. Instead, the "why" comes down to basic supply and demand for NHI's stock.
The $63 resistance level is a price where there has been an excess of supply of shares; in other words, it's a spot where sellers have previously been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above $63 so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.
No comments:
Post a Comment